Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Domperidone-associated QT prolongation in hospitalized adults
NL-OMON40915Not yet recruiting
- Sponsor
- Erasmus MC
- Start
- Sep 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of domperidone in Nausea and Vomiting, sponsored by Erasmus MC. Primary endpoint: QT time on ECG after fourth domperidone dose. Planned start Sep 2014; status: not yet recruiting.
02
Drugs
domperidone
03
Conditions
Nausea and Vomiting
Beyond the preview
Go deeper on NL-OMON40915.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON40915.